Risk of Pneumonitis and Outcomes After Mediastinal Proton Therapy for Relapsed/Refractory Lymphoma: A PTCOG and PCG Collaboration.
Tseng YD, Hoppe BS, Dedeckova K, Patel CG, Hill-Kayser CE, Miller DM, Maity A, Mendenhall NP, Mailhot Vega RB, Yock TI, Baliga S, Hess CB, Winkfield KM, Mohindra P, Rosen LR, Tsai H, Chang J, Hartsell WF, Plastaras JP.
Tseng YD, et al. Among authors: mendenhall np.
Int J Radiat Oncol Biol Phys. 2021 Jan 1;109(1):220-230. doi: 10.1016/j.ijrobp.2020.08.055. Epub 2020 Aug 28.
Int J Radiat Oncol Biol Phys. 2021.
PMID: 32866566
Clinical Trial.